Statement of Organization, Functions, and Delegations of Authority, 50223-50224 [2011-20355]

Download as PDF Federal Register / Vol. 76, No. 156 / Friday, August 12, 2011 / Notices NICEATM–ICCVAM Web site (https:// iccvam.niehs.nih.gov). Application Selection Process References WHO. 2010. Rabies vaccines: WHO Position paper. Weekly Epidemiological Record 85(32):309–320. Dated: August 3, 2011. John R. Bucher, Associate Director, National Toxicology Program. [FR Doc. 2011–20540 Filed 8–11–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice To Change Catalog of Federal Domestic Assistance (CFDA) Number Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: This notice provides public announcement of CDC’s intent to award two awards to eligible applicants of State or Territorial Public Health Newborn Bloodspot Screening Programs. These activities are proposed by the above-mentioned grantees in their FY 2011 applications submitted under funding opportunity CDC–RFA– EH11–001, ‘‘Program to Support New Implementation of State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening of Severe Combined Immune Deficiency (SCID) (U01), ’’ Catalog of Federal Domestic Assistance Number (CFDA): 93.070. Approximately $900,000 in funding will be awarded to the grantees for the implementation of newborn screening for SCID. Accordingly, CDC adds the following information to the previously published funding opportunity announcement of EH11–001: SUMMARY: Authority: Authorized under Section 301 of the Public Health Service Act, [42 U.S.C. 241], as amended. CFDA #: 93.070 Environmental Public Health Emergency Response. mstockstill on DSK4VPTVN1PROD with NOTICES Award Information Type of Award: New Competing Cooperative Agreement. Approximate Total Current Fiscal Year ACA Funding: $900,000. Anticipated Number of Awards: 2. Fiscal Year Funds: 2011. Anticipated Award Date: September 1, 2011. VerDate Mar<15>2010 16:37 Aug 11, 2011 Jkt 223001 Funding will be awarded to applicants based on results from the peer review panel ranking recommendations. Funding Authority CDC will add the authority to that which is reflected in the published Funding Opportunity CDC–RFA–EH11– 001. The revised funding authority language will read: —Authorized under Section 301 of the Public Health Service Act, [42 U.S.C. 241], as amended. DATES: The effective date for this action is the date of publication of this Notice and remains in effect until the expiration of the project period of the funded applications. FOR FURTHER INFORMATION CONTACT: Beth Gardner, Extramural Team Lead, National Center for Environmental Health, Centers for Disease Control and Prevention, 4770 Buford Hwy., Atlanta, GA 30341, telephone (770) 488–0572, email Bgardner@cdc.gov. SUPPLEMENTARY INFORMATION: None. Dated: August 3, 2011. James Stephens, Director of the Office of Science Quality, Centers for Disease Control and Prevention. [FR Doc. 2011–20507 Filed 8–11–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Statement of Organization, Functions, and Delegations of Authority Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 76 FR 47189–47190, dated August 4, 2011) is amended to reflect the reorganization of the Center for Global Health, Centers for Disease Control and Prevention. Section C–B, Organization and Functions, is hereby amended as follows: After the title and functional statements for the Division of Global Disease Detection and Emergency Response (CWJ), insert the following: Global Immunization Division (CWK). The Global Immunization Division (GID) protects the health of Americans and global citizens by preventing PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 50223 disease, disability, and death worldwide from vaccine-preventable diseases. In carrying out its mission, GID: (1) Provides national leadership and coordination of the CGH efforts to eradicate polio, control or eliminate measles, strengthen routine immunization programs, introduce new and under-utilized vaccines, and promote safe injection practices, in collaboration with international organizations and CDC Centers/ Institute/Offices; (2) provides short- and long-term consultation and technical assistance to the WHO, UNICEF, and foreign countries involved in global immunization activities and participates in international advisory group meetings on immunization issues; (3) administers grants to WHO, Pan American Health Organization (PAHO), UNICEF, and other international partners as appropriate for the provision of technical, programmatic, and laboratory support, and vaccine procurement for initiatives to support global immunization targets; (4) designs and participates in international research, monitoring, and evaluation projects to increase the effectiveness of immunization strategies as may be developed; (5) develops strategies to improve the technical skills and problem-solving abilities of program managers and health care workers in other countries; (6) refines strategies developed for the eradication or control of vaccine-preventable diseases in the Western Hemisphere for implementation in other parts of the world; (7) assists other countries, WHO, and other partners to improve surveillance for polio, measles, and other vaccine preventable diseases (VPDs); (8) prepares articles based on findings for publication in international professional journals and presentation at international conferences; (9) collaborates with other countries, WHO, UNICEF, and advocacy groups to ensure the availability of sufficient funds to purchase an adequate supply of polio, measles, and other vaccines, and funds for technical support for use in eradication and control efforts; and (10) provides technical and operational leadership for CDC’s activities in support of the immunization initiatives such as Global Alliance for Vaccines and Immunization and the Global Immunization Vision and Strategies. Office of the Director (CWK1). (1) Provides leadership, management, and oversight for all division activities; (2) provides coordination of budgeting and liaison with CGH, and FMO on budget and spending; (3) provides coordination and oversight of the division’s E:\FR\FM\12AUN1.SGM 12AUN1 mstockstill on DSK4VPTVN1PROD with NOTICES 50224 Federal Register / Vol. 76, No. 156 / Friday, August 12, 2011 / Notices personnel actions including liaison with CGH and CDC’s human resource office; (4) develops and promotes partnerships with other organizations to support global immunization activities; (5) liaises and coordinates with other CDC offices engaged in global immunization activities; (6) provides coordination and oversight of division research and scientific publications, and liaison with other CDC offices involved in scientific oversight; (7) provides coordination of the division communications activities including liaison with other CDC communications offices and those of our partner agencies; (8) represents CDC, CGH, and the division at global and national meetings and other fora for global immunization activities; and (9) provides oversight for all Embassy/ International Cooperative Administrative Supportive Services costs for the division’s field staff. Vaccine Preventable Disease Eradication and Elimination Branch (CWKB). (1) Plans, coordinates, and directs, in collaboration with partners, technical and programmatic activities to eradicate or eliminate/control targeted VPDS; (2) participates in developing and implements improvements to immunization services, surveillance, monitoring, evaluation, and data management program elements for targeted diseases; (3) manages teams that coordinate regional activities and provide guidance and support to the Vaccine Preventable Disease Eradication and Elimination Branch (VPDEEB) staff assigned in the European Region, Eastern Mediterranean Region, African Region, South East Asia Region, and Western Pacific Region WHO regions; (4) participates in multilateral collaborations with an extensive array of CDC and external partners engaged in VPD eradication and elimination including: participating countries, other CDC organizations, other U.S. Government organizations, international organizations including WHO, the United Nations Foundation, UNICEF, and the World Bank; nongovernmental, private sector organizations and vaccine producers, and international advisory committees; (5) provides subject-matter expertise, short- and long-term consultations, and coordinates epidemiology, surveillance, and laboratory activities for programs to eradicate and eliminate VPDs; (6) participates in operation research, monitoring and evaluation projects and studies to improve VPD eradication and control programs and prepares articles based on findings for publication in international professional journals and presentation at international VerDate Mar<15>2010 16:37 Aug 11, 2011 Jkt 223001 conferences; (7) assists with outbreak investigations and emergency response activities; (8) provides technical management for grants and cooperatives agreements for vaccine procurement and for provision of technical, programmatic, and laboratory support. Strengthening Immunization Systems Branch (CWKC). (1) Develops and brings to routine operational level, in collaboration with partners, programs to deliver established, newly available, or under-utilized vaccines for diseases of global importance; (2) assesses the impact of immunization service delivery through surveillance, monitoring of vaccine coverage, and operations research; (3) develops, evaluates, and recommends improvements to strengthen routine immunization programs, including those related to laboratory-based and integrated surveillance systems; immunization coverage, economic evaluations and post-introduction evaluations; (4) provides subject-matter expertise and short- and long-term consultations; (5) participates in multilateral collaborations with an extensive array of CDC and external partners engaged in delivery of routine services, surveillance, and coverage monitoring of VPDs including: participating countries, other CDC organizations, other U.S. Government organizations, international organizations including WHO, the United Nations Foundation, UNICEF, and the World Bank; nongovernmental, private sector organizations and vaccine producers, and international advisory committees; (6) assists partner countries to build capacity in the areas of service delivery, surveillance, health information systems, data management, laboratory services and surveillance, and decisionmaking to achieve effective, efficient, and sustainable immunization programs; (7) manages and provides guidance and support for the GID PAHO team that coordinates PAHO regional activities; (8) evaluates, in collaboration with partners, projects that integrate non-vaccine interventions with routine immunization programs; (9) designs and participates in research, monitoring and evaluation projects and studies to improve existing and newly developing VPD control and eradication programs and prepares articles based on findings for publication in international professional journals and presentation at international conferences; (10) assists with outbreak investigations and emergency response activities. Delete in its entirety the functional statements for the Global Immunization Division (CVGC) within the National PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 Center for Immunization and Respiratory Diseases (CVG). Dated: August 3, 2011. Carlton Duncan, Acting Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2011–20355 Filed 8–11–11; 8:45 am] BILLING CODE 4160–18–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–5502–N2] Medicare Program; Accountable Care Organization Accelerated Development Learning Sessions; Center for Medicare and Medicaid Innovation, September 15th and 16th, 2011 Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice of meeting. AGENCY: This notice announces the date and location of the second in a series of public educational sessions hosted by the Centers for Medicare & Medicaid Services (CMS). This two-day training session is the second Accelerated Development Learning Session (ADLS) hosted by CMS to help Accountable Care Organizations (ACOs) deliver better care and reduce costs. We invite all new or existing ACO entities to register a team of senior executives to attend the in-person ADLS. The ADLS will provide executives with the opportunity to learn about core functions of an ACO and ways to build their organization’s capacity to succeed as an ACO. DATES: Meeting Date: Thursday, September 15, 2011, 8 a.m to 5 pm., pacific daylight time (p.d.t): Friday, September 16, 2011, 8 a.m. to 5 p.m. (p.d.t). Deadline for Meeting Registration: Registration for the second ADLS will remain open until capacity has been reached for the September 15 through 16 in-person meeting. Space is limited and participants are encouraged to register as soon as possible. ADDRESSES: Meeting Location: The second ADLS will be held at the Hyatt Regency San Francisco Airport at 1333 Bayshore Highway, Burlingame, CA 94010. Participants are responsible for their own travel, parking, meals, and overnight stay expenses. More information about the venue and accommodations can be found at https://acoregister.rti.org/. Potential participants are also strongly SUMMARY: E:\FR\FM\12AUN1.SGM 12AUN1

Agencies

[Federal Register Volume 76, Number 156 (Friday, August 12, 2011)]
[Notices]
[Pages 50223-50224]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-20355]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Statement of Organization, Functions, and Delegations of 
Authority

    Part C (Centers for Disease Control and Prevention) of the 
Statement of Organization, Functions, and Delegations of Authority of 
the Department of Health and Human Services (45 FR 67772-76, dated 
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as 
amended most recently at 76 FR 47189-47190, dated August 4, 2011) is 
amended to reflect the reorganization of the Center for Global Health, 
Centers for Disease Control and Prevention.
    Section C-B, Organization and Functions, is hereby amended as 
follows: After the title and functional statements for the Division of 
Global Disease Detection and Emergency Response (CWJ), insert the 
following:
    Global Immunization Division (CWK). The Global Immunization 
Division (GID) protects the health of Americans and global citizens by 
preventing disease, disability, and death worldwide from vaccine-
preventable diseases. In carrying out its mission, GID: (1) Provides 
national leadership and coordination of the CGH efforts to eradicate 
polio, control or eliminate measles, strengthen routine immunization 
programs, introduce new and under-utilized vaccines, and promote safe 
injection practices, in collaboration with international organizations 
and CDC Centers/Institute/Offices; (2) provides short- and long-term 
consultation and technical assistance to the WHO, UNICEF, and foreign 
countries involved in global immunization activities and participates 
in international advisory group meetings on immunization issues; (3) 
administers grants to WHO, Pan American Health Organization (PAHO), 
UNICEF, and other international partners as appropriate for the 
provision of technical, programmatic, and laboratory support, and 
vaccine procurement for initiatives to support global immunization 
targets; (4) designs and participates in international research, 
monitoring, and evaluation projects to increase the effectiveness of 
immunization strategies as may be developed; (5) develops strategies to 
improve the technical skills and problem-solving abilities of program 
managers and health care workers in other countries; (6) refines 
strategies developed for the eradication or control of vaccine-
preventable diseases in the Western Hemisphere for implementation in 
other parts of the world; (7) assists other countries, WHO, and other 
partners to improve surveillance for polio, measles, and other vaccine 
preventable diseases (VPDs); (8) prepares articles based on findings 
for publication in international professional journals and presentation 
at international conferences; (9) collaborates with other countries, 
WHO, UNICEF, and advocacy groups to ensure the availability of 
sufficient funds to purchase an adequate supply of polio, measles, and 
other vaccines, and funds for technical support for use in eradication 
and control efforts; and (10) provides technical and operational 
leadership for CDC's activities in support of the immunization 
initiatives such as Global Alliance for Vaccines and Immunization and 
the Global Immunization Vision and Strategies.
    Office of the Director (CWK1). (1) Provides leadership, management, 
and oversight for all division activities; (2) provides coordination of 
budgeting and liaison with CGH, and FMO on budget and spending; (3) 
provides coordination and oversight of the division's

[[Page 50224]]

personnel actions including liaison with CGH and CDC's human resource 
office; (4) develops and promotes partnerships with other organizations 
to support global immunization activities; (5) liaises and coordinates 
with other CDC offices engaged in global immunization activities; (6) 
provides coordination and oversight of division research and scientific 
publications, and liaison with other CDC offices involved in scientific 
oversight; (7) provides coordination of the division communications 
activities including liaison with other CDC communications offices and 
those of our partner agencies; (8) represents CDC, CGH, and the 
division at global and national meetings and other fora for global 
immunization activities; and (9) provides oversight for all Embassy/
International Cooperative Administrative Supportive Services costs for 
the division's field staff.
    Vaccine Preventable Disease Eradication and Elimination Branch 
(CWKB). (1) Plans, coordinates, and directs, in collaboration with 
partners, technical and programmatic activities to eradicate or 
eliminate/control targeted VPDS; (2) participates in developing and 
implements improvements to immunization services, surveillance, 
monitoring, evaluation, and data management program elements for 
targeted diseases; (3) manages teams that coordinate regional 
activities and provide guidance and support to the Vaccine Preventable 
Disease Eradication and Elimination Branch (VPDEEB) staff assigned in 
the European Region, Eastern Mediterranean Region, African Region, 
South East Asia Region, and Western Pacific Region WHO regions; (4) 
participates in multilateral collaborations with an extensive array of 
CDC and external partners engaged in VPD eradication and elimination 
including: participating countries, other CDC organizations, other U.S. 
Government organizations, international organizations including WHO, 
the United Nations Foundation, UNICEF, and the World Bank; 
nongovernmental, private sector organizations and vaccine producers, 
and international advisory committees; (5) provides subject-matter 
expertise, short- and long-term consultations, and coordinates 
epidemiology, surveillance, and laboratory activities for programs to 
eradicate and eliminate VPDs; (6) participates in operation research, 
monitoring and evaluation projects and studies to improve VPD 
eradication and control programs and prepares articles based on 
findings for publication in international professional journals and 
presentation at international conferences; (7) assists with outbreak 
investigations and emergency response activities; (8) provides 
technical management for grants and cooperatives agreements for vaccine 
procurement and for provision of technical, programmatic, and 
laboratory support.
    Strengthening Immunization Systems Branch (CWKC). (1) Develops and 
brings to routine operational level, in collaboration with partners, 
programs to deliver established, newly available, or under-utilized 
vaccines for diseases of global importance; (2) assesses the impact of 
immunization service delivery through surveillance, monitoring of 
vaccine coverage, and operations research; (3) develops, evaluates, and 
recommends improvements to strengthen routine immunization programs, 
including those related to laboratory-based and integrated surveillance 
systems; immunization coverage, economic evaluations and post-
introduction evaluations; (4) provides subject-matter expertise and 
short- and long-term consultations; (5) participates in multilateral 
collaborations with an extensive array of CDC and external partners 
engaged in delivery of routine services, surveillance, and coverage 
monitoring of VPDs including: participating countries, other CDC 
organizations, other U.S. Government organizations, international 
organizations including WHO, the United Nations Foundation, UNICEF, and 
the World Bank; non-governmental, private sector organizations and 
vaccine producers, and international advisory committees; (6) assists 
partner countries to build capacity in the areas of service delivery, 
surveillance, health information systems, data management, laboratory 
services and surveillance, and decision-making to achieve effective, 
efficient, and sustainable immunization programs; (7) manages and 
provides guidance and support for the GID PAHO team that coordinates 
PAHO regional activities; (8) evaluates, in collaboration with 
partners, projects that integrate non-vaccine interventions with 
routine immunization programs; (9) designs and participates in 
research, monitoring and evaluation projects and studies to improve 
existing and newly developing VPD control and eradication programs and 
prepares articles based on findings for publication in international 
professional journals and presentation at international conferences; 
(10) assists with outbreak investigations and emergency response 
activities.
    Delete in its entirety the functional statements for the Global 
Immunization Division (CVGC) within the National Center for 
Immunization and Respiratory Diseases (CVG).

    Dated: August 3, 2011.
Carlton Duncan,
Acting Chief Operating Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2011-20355 Filed 8-11-11; 8:45 am]
BILLING CODE 4160-18-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.